Using multivariate models with NIR and Raman data for advanced process control

Using Multivariate Models with NIR and Raman Data for Advanced Process Control Using Multivariate Models with NIR and Raman Data for Advanced Process Control In the context of pharmaceutical manufacturing, the implementation of Process Analytical Technology (PAT) has become increasingly essential for ensuring product quality and compliance with regulatory standards. As part of these initiatives, the integration of Near-Infrared (NIR) and Raman spectroscopy with advanced multivariate modeling techniques can play a critical role in real-time process control and the management of critical quality attributes (CQAs). This article provides a comprehensive overview of using multivariate models with NIR and Raman data,…

Continue Reading... Using multivariate models with NIR and Raman data for advanced process control

Cybersecurity and connectivity considerations for networked PAT sensors

Cybersecurity and Connectivity Considerations for Networked PAT Sensors Cybersecurity and Connectivity Considerations for Networked PAT Sensors Process Analytical Technology (PAT) is a critical paradigm within the pharmaceutical industry that supports process understanding and real-time monitoring. The integration of advanced technologies such as near-infrared (NIR) spectroscopy and Raman spectroscopy into PAT frameworks has enabled pharmaceutical professionals to adopt inline, online, and at-line testing methods. However, with the rapid advancement of digitalization, the cybersecurity of networked PAT sensors presents not only regulatory compliance challenges but also significant operational risks. This article aims to provide a comprehensive overview of the cybersecurity issues, data…

Continue Reading... Cybersecurity and connectivity considerations for networked PAT sensors

Developing rapid spectroscopic methods to replace slow offline testing for CPPs

Developing Rapid Spectroscopic Methods to Replace Slow Offline Testing for CPPs Developing Rapid Spectroscopic Methods to Replace Slow Offline Testing for CPPs In the ever-evolving landscape of pharmaceutical manufacturing, the need for agility and efficiency is paramount. Regulatory bodies such as the FDA in the United States, the EMA in the EU, and the MHRA in the UK have emphasized the adoption of Process Analytical Technology (PAT) to enhance manufacturing processes and ensure product quality. This article aims to provide a comprehensive overview of developing rapid spectroscopic methods to replace traditional offline testing for Critical Process Parameters (CPPs). Understanding Process…

Continue Reading... Developing rapid spectroscopic methods to replace slow offline testing for CPPs

Aligning PAT analytics for biologics with fda process and bioanalytical validation guidance

Aligning PAT Analytics for Biologics with FDA Process and Bioanalytical Validation Guidance Aligning PAT Analytics for Biologics with FDA Process and Bioanalytical Validation Guidance The increasing complexity of biologics production necessitates the development of robust analytical methods to ensure product quality. Process Analytical Technology (PAT) has emerged as a key component in modern biomanufacturing, helping companies meet stringent regulatory expectations. This article provides a comprehensive overview of how PAT analytics, specifically employing techniques such as NIR and Raman spectroscopy, align with FDA process validation guidance and bioanalytical method validation guidance for the industry. The goal is to elucidate precisely how…

Continue Reading... Aligning PAT analytics for biologics with fda process and bioanalytical validation guidance

Managing model drift and instrument variability for spectroscopic PAT tools

Managing Model Drift and Instrument Variability for Spectroscopic PAT Tools Managing Model Drift and Instrument Variability for Spectroscopic PAT Tools In the ever-evolving landscape of pharmaceutical manufacturing, the integration of Process Analytical Technology (PAT) tools has been paramount for enhancing efficiency, ensuring product quality, and adhering to regulatory compliance. As organizations leverage technologies such as Near-Infrared (NIR) spectroscopy and Raman spectroscopy, it becomes crucial to address challenges such as model drift and instrument variability. Understanding the regulatory implications surrounding these topics is essential for professionals in clinical operations, regulatory affairs, and medical affairs. Understanding Model Drift in Spectroscopic PAT Tools…

Continue Reading... Managing model drift and instrument variability for spectroscopic PAT tools

Case studies where inline NIR enabled real time release testing in compression

Case Studies Where Inline NIR Enabled Real-Time Release Testing in Compression Case Studies Where Inline NIR Enabled Real-Time Release Testing in Compression In recent years, the pharmaceutical industry has evolved significantly, integrating technological advancements to enhance compliance and operational efficiency. The implementation of real-time release testing (RTRT) using inline Near-Infrared (NIR) spectroscopy has gained traction as a promising and efficient approach to affirm product quality in compressed formulations. This article aims to elucidate the case studies where inline NIR analytics enabled effective RTRT in compression, thereby aligning with the FDA’s process validation guidance and overall bioanalytical method validation guidance for…

Continue Reading... Case studies where inline NIR enabled real time release testing in compression

Future of online analytics hyperspectral imaging, advanced sensors and FDA expectations

Future of Online Analytics Hyperspectral Imaging, Advanced Sensors and FDA Expectations Future of Online Analytics Hyperspectral Imaging, Advanced Sensors and FDA Expectations Overview of Process Analytical Technology (PAT) Process Analytical Technology (PAT) represents a systematic approach to the design, analysis, and control of manufacturing processes through timely measurements of critical quality and performance attributes. The core of PAT is to enhance understanding of the processes impacting product quality while promoting innovation, compliance, and efficiency across pharmaceutical operations. The FDA supports the integration of advanced analytical technologies, including inline, at-line, and online measurements, to facilitate real-time monitoring and control of pharmaceutical…

Continue Reading... Future of online analytics hyperspectral imaging, advanced sensors and FDA expectations

Dashboards and visualization of PAT sensor outputs for operators and QA

Dashboards and Visualization of PAT Sensor Outputs for Operators and QA Dashboards and Visualization of PAT Sensor Outputs for Operators and QA In the pharmaceutical industry, the integration of Process Analytical Technology (PAT) plays a vital role in achieving efficient process control and ensuring product quality. This article explores the design and implementation of dashboards and visualization tools for real-time monitoring of PAT sensor outputs, aligning with regulatory guidance to improve operational efficiency and compliance. Understanding Process Analytical Technology (PAT) Process Analytical Technology (PAT) is defined by the FDA in its guidance documents as a system for designing, analyzing, and…

Continue Reading... Dashboards and visualization of PAT sensor outputs for operators and QA

Sample handling, reference standards and calibration sets for PAT spectroscopy

Sample handling, reference standards and calibration sets for PAT spectroscopy Sample handling, reference standards and calibration sets for PAT spectroscopy The introduction of Process Analytical Technology (PAT) has revolutionized the pharmaceutical industry by enabling continuous monitoring and control of manufacturing processes. The use of Near-Infrared (NIR) and Raman spectroscopy has gained traction as viable inline and at-line analytical methods to ensure product quality and process efficiency. This article provides a comprehensive exploration of sample handling, reference standards, and calibration sets critical to PAT spectroscopy, in alignment with FDA guidance and global regulatory expectations. Understanding the Role of PAT in Pharmaceutical…

Continue Reading... Sample handling, reference standards and calibration sets for PAT spectroscopy

Regulatory expectations when replacing compendial tests with PAT spectroscopy

Regulatory expectations when replacing compendial tests with PAT spectroscopy Regulatory Expectations When Replacing Compendial Tests with PAT Spectroscopy The pharmaceutical industry is under constant pressure to ensure product quality while maintaining efficient production processes. As a consequence, Process Analytical Technology (PAT) has gained significant traction in recent years, promising enhancements in real-time process monitoring and real-time release testing (RTRT). Among the various PAT methodologies, spectroscopic techniques like Near-Infrared (NIR) and Raman spectroscopy are increasingly being considered as alternatives to traditional compendial tests. This article will explore the regulatory expectations surrounding the implementation of these PAT methodologies in place of compendial…

Continue Reading... Regulatory expectations when replacing compendial tests with PAT spectroscopy